Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Farhad Ravandi
Clofarabine, Idarubicin, and Cytarabine (CIA) as Frontline Therapy for Patients <= 60 Years With Newly Diagnosed Acute Myeloid Leukemia (AML)
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Transglutaminase2 Expression in Acute Myeloid Leukemia: Association With Adhesion Molecule Expression and Leukemic Blast Motility
Blood
Biochemistry
Immunology
Cell Biology
Hematology
10-Day vs 5-Day Decitabine: Equivalence Cannot Be Concluded – Authors' Reply
The Lancet Haematology
Hematology
Long-Term Molecular and Cytogenetic Response and Survival Outcomes With Imatinib 400 Mg, Imatinib 800 Mg, Dasatinib, and Nilotinib in Patients With Chronic-Phase Chronic Myeloid Leukaemia: Retrospective Analysis of Patient Data From Five Clinical Trials
The Lancet Haematology
Hematology
Acute Myeloid Leukemia
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini-Hyper-Cvd, With or Without Blinatumomab, Is Highly Effective in Patients With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Salvage
Cancer
Cancer Research
Oncology
FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia
Cancer
Cancer Research
Oncology
Imatinib Front-Line Therapy Is Safe and Effective in Patients With Chronic Myelogenous Leukemia With Pre-Existing Liver and/or Renal Dysfunction
Cancer
Cancer Research
Oncology
The Distribution of T-Cell Subsets and the Expression of Immune Checkpoint Receptors and Ligands in Patients With Newly Diagnosed and Relapsed Acute Myeloid Leukemia
Cancer
Cancer Research
Oncology
How Close Are We to Incorporating Measurable Residual Disease Into Clinical Practice for Acute Myeloid Leukemia?
Haematologica
Hematology
1
2
3
4
5
›
